1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 04 APRIL 2016

World Generic Markets 04 APRIL 2016

  • April 2016
  • -
  • Espicom Business Intelligence
  • -
  • 28 pages

Industry Trend Analysis - IGBA Special 301 Submission Highlights Need For Common Ground
Industry Brief - Sandoz Canada Launches Tobramycin Authorised Generic
Industry Brief - Biocon Enters Insulin Agreement With Lab PiSA
Industry Trend Analysis - Prize Fund Concept Rethinks Innovation/Reward Model
Industry Brief - Allergan Confirms Paclitaxel Patent Challenge
Industry Brief - Breckenridge Gains Gabapentin Approval
Industry Brief - Orchid Gains Rasagiline Approval
Industry Brief - Glenmark Gains Frovatriptan Approval And Lacosamide Tentative Approval
Industry Brief - Aurobindo's Ibandronate Approved
Industry Brief - Teligent Launches Cefotetan
Industry Brief - Teva Launches Acamprosate In US
Industry Brief - Lupin Completes Gavis And Novel Acquisitions
Industry Brief - Apotex Launches Mometasone Nasal Spray
Industry Brief - Perrigo And Allergan Launch OTC Guaifenesin
Industry Trend Analysis - Lialda Weathers Generic Storms But Remains At Threat From PTO Ruling
Industry Brief - Rising Launches Lithium Carbonate And Metronidazole Tablets
Industry Brief - Ajanta Launches Levetiracetam In US
Industry Brief - Aurobindo Gains New US Drug Approvals
Industry Brief - Amneal Launches Diclofenac Sodium Gel
Industry Brief - Hikma, Lannett Gain Temolozomide Approvals
Industry Brief - Lannett Gains Potassium Chloride Approval
Industry Brief - Mylan Launches Tramadol ER Tablets
Industry Brief - Lupin Launches Donepezil Tablets
Industry Brief - ANI Receives Oxycodone Approval
Industry Brief - ANI Closes Inderal LA Acquisition
Industry Trend Analysis - Inter Partes Review Case Will Hold Timely Generic Access In The Balance
Industry Trend Analysis - Perrigo Seeks To Improve Branded Consumer Healthcare Business
Industry Brief - Actavis Launches Gliclazide In UK
Industry Trend Analysis - GSK's Access Proposal Is Bold But Implementation Will Be Key
Industry Brief - Teva Takeda Yakuhin Established
Industry Trend Analysis - Hikma Looking To US To Boost Sales

Table Of Contents

World Generic Markets 04 APRIL 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.